For example, relative to normal healthy subjects, serum RANKL concentrations are reported to increase 2.65-fold [69], 2.26-fold [70], 13.5-fold [71], and 15.67-fold [72] in patients with stage III MM. This evidence concerns the gene TNFSF11 and Miyoshi myopathy.